BioSpace News Archive

SAINT LAURENT, Quebec, Feb. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “ Company ” or “ IntelGenx ”) is pleased to announce that it has closed its offering (the “ Offering ”) of 16,317,000 units (the “ Units ”) at a price of C$0.50 per Unit (the “ Offering Price ”) for gross proceeds of C$8,158,500. Each Unit consists of one share of common stock (the “ Offered Shares ”) and one warrant (a “ Warrant ”) entitling the holder to purchase one share o

The 2019 novel coronavirus is driving a surge in demand for disposable medical supplies in China, where the market totaled $27.2 billion in 2017, according to a Freedonia Group analysis

Harpak-ULMA announced availability of a flow-pack solution capable of applying a chevron seal for medical packaging.

The Association of Public Health Laboratories is pleased to announce the fall 2019 recipients of the Expansion of Spinal Muscular Atrophy Newborn Screening Project awards.

MRI Interventions, Inc., a leading platform neurosurgery company, will effectuate its previously announced change of its corporate name to ClearPoint Neuro, Inc.

Last month, authors from Montana State University, in conjunction with the Center for Asbestos Related Disease in Libby, MT, published a manuscript in the peer reviewed journal, Inhalation Toxicology, titled, “Autoimmune Markers for Progression of Libby Amphibole Lamellar Pleural Thickening.” According to lead author, Jean Pfau, PhD, “We have long suspected that the immune system could drive progression of Libby’s devastating pleural disease, based on clinical observations and studies in mice.

“Having family members with diabetes, I was interested in finding an alternative means of measuring their blood glucose levels and delivering insulin,” said an inventor from Reading, Pa. “I think my system will offer a better means of controlling diabetes.”.

Applied Research Works, Inc. announced Cozeva Bridge, a new service in Cozeva that consolidates medical information and incentives from health care provider groups and insurers into a unified view.

By the time they reach menopause — which officially begins one year after a woman’s last period — many women think they have their lives figured out.

At the request of the Investment Industry Regulatory Organization of Canada, Nuvo Pharmaceuticals Inc. wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its common shares.